Muss HB - Search Results

1

Association of p16(INK4a), a biomarker of cellular senescence, with receipt of therapy and frailty status among adults with plasma cell disorders.

Jensen CE, Deal AM, Srikanth S, Nyrop KA, Mitin N, LeBlanc MR, Muss HB, Rubinstein SM, Tuchman SA, Lichtman EI. Jensen CE, et al. Among authors: muss hb. J Geriatr Oncol. 2024 Dec 20:102174. doi: 10.1016/j.jgo.2024.102174. Online ahead of print. J Geriatr Oncol. 2024. PMID: 39706780 No abstract available.

2

The Role of p16Ink4a as an Early Predictor of Physiological Decline during Natural Aging.

Tang L, Hladyshau S, Ross A, Nyrop KA, Entwistle A, Muss HB, Mitin N, Tsygankov D. Tang L, et al. Among authors: muss hb. medRxiv [Preprint]. 2024 Nov 22:2024.11.21.24317752. doi: 10.1101/2024.11.21.24317752. medRxiv. 2024. PMID: 39606419 Free PMC article. Preprint.

3

Profiling an integrated network of cellular senescence and immune resilience measures in natural aging: a prospective multi-cohort study.

Mitin N, Entwistle A, Knecht A, Strum SL, Ross A, Nyrop K, Muss HB, Tsygankov D, Raffaele JM. Mitin N, et al. Among authors: muss hb. medRxiv [Preprint]. 2023 Dec 28:2023.08.25.23294589. doi: 10.1101/2023.08.25.23294589. medRxiv. 2023. PMID: 37693401 Free PMC article. Preprint.

4

Associations of social vulnerability index with patient-reported outcomes in women treated with chemotherapy for early-stage breast cancer.

Almond N, Deal AM, Page A, Nyrop KA, Muss HB. Almond N, et al. Among authors: muss hb. Oncologist. 2024 Nov 26:oyae311. doi: 10.1093/oncolo/oyae311. Online ahead of print. Oncologist. 2024. PMID: 39589218 Free article.

5

Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.

Morse RT, Bean NW, Hall J, Deal A, Nyrop KA, Abdou Y, Dees EC, Ray EM, Jolly TA, Reeder-Hayes KE, Jones E, Gupta GP, Elmore S, Muss HB, Casey DL. Morse RT, et al. Among authors: muss hb. Clin Breast Cancer. 2025 Jan;25(1):e86-e93. doi: 10.1016/j.clbc.2024.08.015. Epub 2024 Aug 30. Clin Breast Cancer. 2025. PMID: 39317637

6

A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.

File DM, Abdou Y, Force J, Moore DT, Anders CK, Reeder-Hayes K, Carey LA, Muss HB, Perou CM, Marcom PK, Dees EC. File DM, et al. Among authors: muss hb. Clin Breast Cancer. 2024 Dec;24(8):683-690. doi: 10.1016/j.clbc.2024.08.001. Epub 2024 Aug 8. Clin Breast Cancer. 2024. PMID: 39217059 Clinical Trial.

7

Dose delay, dose reduction, and early treatment discontinuation in Black and White women receiving chemotherapy for nonmetastatic breast cancer.

Forster M, Deal AM, Page A, Vohra S, Wardell AC, Pak J, Lund JL, Nyrop KA, Muss HB. Forster M, et al. Among authors: muss hb. Oncologist. 2024 Oct 3;29(10):e1246-e1259. doi: 10.1093/oncolo/oyae150. Oncologist. 2024. PMID: 38913986 Free PMC article.

8

Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601).

Sedrak MS, Lee MK, Ji J, Satele DV, Freedman RA, Poorvu PD, O'Connor T, Williams GR, Hopkins JO, Muss HB, Cohen HJ, Partridge AH, Carey LA, Chow SL, Subbiah N, Le-Rademacher J, Jatoi A. Sedrak MS, et al. Among authors: muss hb. J Geriatr Oncol. 2024 Jul;15(6):101813. doi: 10.1016/j.jgo.2024.101813. Epub 2024 Jun 8. J Geriatr Oncol. 2024. PMID: 38852379 Free PMC article. Clinical Trial.

9

"They don't care to study it": Trust, race, and health care experiences among patient-caregiver dyads with multiple myeloma.

Grant SJ, Mills JA, Telfair J, Erisnor G, Wildes TM, Bates-Fraser LC, Olshan AF, Kent EE, Muss HB, Mihas P. Grant SJ, et al. Among authors: muss hb. Cancer Med. 2024 May;13(10):e7297. doi: 10.1002/cam4.7297. Cancer Med. 2024. PMID: 38770636 Free PMC article.

10

Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.

Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, Moy B, Wildes TM, Klepin HD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Muss HB, Cohen HJ, Gross CP, Ji J. Sedrak MS, et al. Among authors: muss hb. J Cancer Surviv. 2024 Aug;18(4):1131-1143. doi: 10.1007/s11764-024-01594-3. Epub 2024 Apr 28. J Cancer Surviv. 2024. PMID: 38678525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters